SCHEMBL8977848

SCHEMBL8977848

COC(=O)c1cccc(C(O[SiH2]C(C)(C)C)(c2ccccc2)c2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
CYP1A2 P05177 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
GAA P10253 1/20 0.39
RECQL P46063 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
TSHR P16473 2/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KCNN4 O15554 1/20 0.36
CES1 P23141 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8977820 0.76 MEN1 (0.33) ALDH1A1
SCHEMBL8777264 0.76 MAPK1 (0.32) ALDH1A1
SCHEMBL2627807 0.76 CYP1A2 (0.53) MAPTCYP1A2SMN1; SMN2NPC1RAB9A
SCHEMBL6170678 0.74 TSHR (0.41) MAPTRAB9AGAAALDH1A1KDM4E
SCHEMBL16834606 0.74 MAPT (0.48) MAPTCYP1A2SMN1; SMN2NPC1RAB9A
SCHEMBL16369847 0.73 MAPT (0.50) MAPTCYP1A2SMN1; SMN2NPC1RAB9A
SCHEMBL22836314 0.73 MAPT (0.50) MAPTCYP1A2SMN1; SMN2NPC1RAB9A
SCHEMBL29502563 0.73 MAPT (0.50) MAPTCYP1A2SMN1; SMN2NPC1RAB9A
SCHEMBL1315596 0.72 MAPK1 (0.44) MAPTCYP3A4CYP2C19ALDH1A1TSHR
SCHEMBL1111138 0.71 P2RX7 (0.61) MAPTCYP1A2SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5559134-A Leukotriene-B4 antagonists, process for their production and their use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1996-09-24 US disclosed